Previous studies on pancreatic cancer cells have found that blocking the interaction between keap1 and Nrf2 results in Nrf2 accumulation in the nucleus, a change in activation of the NF-KB pathway and resistance to malignant cell proliferation [16]. Here, NFE2L2 is linked to pancreatic neoplasm.